Timothy Walker

Tim is a contributing analyst for EconomicCalendar.com and specializes in equities trading and public offerings. He is a graduate of UCLA and began his career doing capital markets research for a top investment banking software provider.

Does Cara Therapeutics (CARA) Have More Room To Grow?

Cara Therapeutics Inc (NASDAQ:CARA) has grown about 55 percent since the beginning of the calendar year, and – with a few catalysts on the...

Depomed (DEPO) Spikes on Fourth-Quarter Earnings Beat

After the market close yesterday, specialty pharmaceutical company Depomed Inc (NASDAQ:DEPO) announced its fourth-quarter and full-year financial results – posting both revenue and adjusted...

Weeks After Its IPO, Analysts Getting On Board with ObsEva SA (OBSV)

ObsEva SA (NASDAQ:OBSV) had a great day yesterday, with three different Wall Street firms initiating coverage on the company’s stock – including three very...

Sarepta (SRPT) Inks Deal Selling Priority Review Voucher to Gilead (GILD)

Sarepta Therapeutics Inc (NASDAQ:SRPT) announced today that it plans on selling its Rare Pediatric Disease Priority Review Voucher (PRV) to Gilead Sciences Inc (NASDAQ:GILD)...

Two Catalysts on the Way for Adamas Pharmaceuticals (ADMS), Says Mizuho

Today, Mizuho Securities reiterated a Buy rating on Adamas Pharmaceuticals Inc (NASDAQ:ADMS), a biotech company that focuses on developing treatments for chronic neurologic disorders....

Analysts Positive on Abeona Therapeutics’ (ABEO) Low-Dose Clinical Trial Data

On Friday, Abeona Therapeutics Inc (NASDAQ:ABEO) released very encouraging data from an ongoing clinical trial evaluating its treatment for mucopolysaccharidosis (MPS) type III –...
dna pharmaceuticals

Plenty of Catalysts Ahead for Cytokinetics (CYTK)

Cytokinetics Inc (NASDAQ:CYTK) released its fourth-quarter financial results after the market close yesterday – and absolutely crushed analyst estimates with both its revenue and...

Pending Cystic Fibrosis Trial Data, PTC Therapeutics (PTCT) is Poised to Break Out

PTC Therapeutics Inc (NASDAQ:PTCT) jumped eight percent higher yesterday, rising $1.02 to hit $13.78 at the market close. The biotech company’s shares were also...

Sage Therapeutics (SAGE) Jumps 12%, Plenty of Upside Still Ahead

Sage Therapeutics Inc (NASDAQ:SAGE) surged nearly 12 percent higher yesterday, rising $5.57 to hit $52.99 at the market close. The boost arrived on the...

Credit Suisse Starts Ascendis Pharma (ASND) at Outperform

Ascendis Pharma A/S (NASDAQ:ASND) jumped 3.33 percent higher yesterday, rising 74 cents to hit $22.96 at the market close. The boost arrived on the...

Upcoming Economic Events

Other News


S&P 500 Futures Tumble After FOMC Minutes Signal Higher Interest Rates Ahead

U.S. equity markets finished mostly lower on Wednesday, after a hawkish reading of the Federal Reserve's previous meeting signaled higher interest rates could be...
oil tanks with oil tanker

API Reports Unexpected 0.88 Million Barrel Inventory Draw, WTI Oil Price Rallies

The latest weekly American Petroleum Institute (API) inventory data for the week ending February 17th reported an inventory draw of 0.88 million barrels. ...
uranium price

Uranium Spot Prices Run Out of Momentum

The uranium spot price rally stalled last week, ending the commodity's ascent that started in December after prices fell as low as $17.75 per...
Canada Dollar USD/CAD

USD/CAD Bulls Disappointed by Fed Minutes

The Canadian dollar weakened after poor retail sales data, but USD/CAD hit resistance above 1.3200 and retreated after the Fed minutes provided no hawkish...

Nickel Prices Tracking US Dollar

Nickel prices were lower Wednesday, even after the commodity fell under significant pressure in the prior session.While all the base metals faced some pressure...